Application of CRISPR in Anti-Tumor Immunotherapy
DOI:
https://doi.org/10.54097/n4ttzw07Keywords:
CRISPR, gene editing, tumor, therapy.Abstract
The requirements for medicine are getting higher and higher, and the cure rate of cancer is increasingly attracting attention. CRISPR/cas9 genome editing technology has gradually attracted more and more attention, and has gradually become popular in research. At present, CRISPR system has been applied in many tumor immunotherapy methods and cancer research. CRISPR system is one of the key issues today, but there is still a lack of unified cognition about applying CRISPR in immunological therapy about cancer. Therefore, the theme of this study is about CRISPR in anti-tumor immunotherapy. More and more researchers are using CRISPR/cas system to improve and innovate the immunotherapy of various types of tumors, which improves the treatment efficiency and effect. At the same time, they provide innovative ideas and feasible ways for more treatment methods. CRISPR system also has some disadvantages, such as off-target effect. With the development of science and technology and more and more innovation and practice, crispr has been applied to cancer treatment to provide a good experience for patients.
Downloads
References
Wu Qi, Wang Shaobo Research progress on the role of CRISPR/Cas9 technology in CAR-T cell therapy for tumors. Basic Medicine and Clinical Journal, 2023, 43 (8): 1313-1316.
Ou X, Ma Q, Yin W, et al. CRISPR/Cas9 gene-editing in cancer immunotherapy: Promoting the present revolution in cancer therapy and exploring more. Frontiers in Cell and Developmental Biology, 2021, 9: 674467.
Shi Mengran, Shen Zongyi, Zhang Nan, et al. The Application of CRISPR/Cas9 System in Disease Research and Treatment. Journal of Biotechnology, 2021, 37 (4): 1205-1228.
Wang S W, Gao C, Zheng Y M, et al. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Molecular cancer, 2022, 21 (1): 1-27.
Ma Mengdan, Yang Yubin, Chen Yanping, etc CRISPR/Cas9 technology and its application in tumor research and treatment. Life Sciences, 2021, 33 (11): 1370-1381.
Zhang H, Qin C, An C, et al. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Molecular Cancer, 2021, 20: 1-22.
Xiong Xiangyu, Bei Jinxin. Application progress of gene editing technology in tumor treatment. Chinese Journal of Cell Biology, 2023, 45 (12): 1746-1756.
Stadtmauer E A, Fraietta J A, Davis M M, et al. CRISPR-engineered T cells in patients with refractory cancer. Science, 2020, 367 (6481): eaba7365.
Chang Zhenyi, Yan Wei, Liu Dongfeng, et al Progress in CRISPR/Cas Technology Research. Journal of Agricultural Biotechnology, 2015, 23 (9): 1196-1206
Liu Yun'en, Zhang Zijing, Luo Zhonghua Research progress on PD-1 monoclonal antibody combined therapy to improve T cell infiltration in tumors. Journal of Jinzhou Medical University, 2023, 44 (5): 1-5.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







